Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status

NCT00689221 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

545

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Cilengitide
DRUG: Temozolomide
RADIATION: Radiotherapy

Sponsor

EMD Serono

Collaborators

[object Object]
[object Object]